What is HFpEF &
How do we make the diagnosis?
Barry Borlaug MD, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
What is HFpEF & How do we make the diagnosis? Barry Borlaug MD, - - PowerPoint PPT Presentation
What is HFpEF & How do we make the diagnosis? Barry Borlaug MD, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA Introduction Review of Heart Failure with Preserved Ejection Fraction: Definition of HFpEF
Barry Borlaug MD, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA
Review of Heart Failure with Preserved Ejection Fraction:
pt w EF≥50%
LAE, LVH, E/e’>13 + e’<9
Ponikowski Eur Heart J 2016
Obokata…Borlaug Circulation 2017
– Mild LAE – E/A 1.1, E/e’ 11, RVSP 32
ESC algorithm says “no HFpEF”
20 40 60 80 100 120 140 160 180
PCWP=LVEDP=12 mmHg; CO 5.7 l/min PCWP=LVEDP=40 mmHg; CO 7.8 l/min 40 Watts Exercise
58% of pts with normal exam, echo, BNP & resting hemos have HF by exercise
<125
% of HFpEF patients
10 20 30 40 50
<200 <300 NT-proBNP cutoff used (pg/ml)
Obokata, Borlaug Circulation 2017
NCD HFpEF 10 20 30 40 50
p<0.0001 E/e’ medial NCD HFpEF
5 10 15 20 25 30 35 10 20 30 40 50 60
PCWP (mm Hg)
r= 0.63 p<0.0001 E/e’ medial PCWP (mm Hg)
Obokata, Borlaug Circulation 2017
NCD HFpEF 10 20 30 40
p<0.0001
Peak VO2 (ml/min/kg)
Reddy, Borlaug JACC Heart Fail 2018
Reddy, Borlaug Circulation 2018
A simplified, Bayesian Approach to Dx: The H2FPEF Score
Valvular heart disease Coronary artery disease Pulmonary arterial hypertension High output heart failure Constrictive pericarditis Infiltrative or restrictive cardiomyopathy Hypertrophic cardiomyopathy Right ventricular myopathies Pulmonary embolism
Cardiac Causes of Dyspnea that may Mimic HFpEF
HFpEF is defined by symptoms (i.e. dyspnea) due to failure of the heart to pump blood adequately to the body at normal filling pressures. The diagnosis of HFpEF is made by demonstrating objective evidence of high filling pressures and/or inadequate cardiac output. This is sometimes achieved by physical exam, echocardiography, natriuretic peptide testing and cardiopulmonary exercise testing, but each of these has limitations in sensitivity. Invasive diastolic stress testing represents the gold standard test to identify or rule out HFpEF. The H2FPEF score can be used to estimate the probability that HFpEF is present in patients with unexplained dyspnea and may inform further workup. Remember to exclude disorders that may mimic HFpEF but are treated differently.